{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:25:46Z","timestamp":1790007946487,"version":"4.0.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["CDA-2018-003"],"award-info":[{"award-number":["CDA-2018-003"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.sapharm.2025.03.009","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T15:08:23Z","timestamp":1742224103000},"page":"549-558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The association between multimorbidity and out-of-pocket expenditure for prescription medicines among adults in Denmark: A population-based register study"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4339-5623","authenticated-orcid":false,"given":"James","family":"Larkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line Due","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Schmidt","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus H\u00f8strup","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Paust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.sapharm.2025.03.009_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2017-000505","article-title":"Multimorbidity and out-of-pocket expenditure on medicines: a systematic review","volume":"3","author":"Sum","year":"2018","journal-title":"BMJ Glob Health"},{"issue":"6","key":"10.1016\/j.sapharm.2025.03.009_bib6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/pds.3917","article-title":"Copayments for prescription medicines on a public health insurance scheme in Ireland","volume":"25","author":"Sinnott","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"10.1016\/j.sapharm.2025.03.009_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-060502","article-title":"What is the impact of multimorbidity on out-of-pocket healthcare expenditure among community-dwelling older adults in Ireland? A cross-sectional study","volume":"12","author":"Larkin","year":"2022","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.sapharm.2025.03.009_bib8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1071\/PY12035","article-title":"Multimorbidity is associated with higher out-of-pocket spending: a study of older Australians with multiple chronic conditions","volume":"19","author":"McRae","year":"2013","journal-title":"Aust J Prim Health"},{"issue":"1","key":"10.1016\/j.sapharm.2025.03.009_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1377\/hlthaff.28.1.15","article-title":"Rising out-of-pocket spending for chronic conditions: a ten-year trend","volume":"28","author":"Paez","year":"2009","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.sapharm.2025.03.009_bib10","article-title":"The experience of financial burden for people with multimorbidity: a systematic review of qualitative research","volume":"2","author":"Larkin","year":"2020","journal-title":"Health Expect"},{"key":"10.1016\/j.sapharm.2025.03.009_bib11","series-title":"Adherence to Long-Term Therapies: Evidence for Action","author":"Sabat\u00e9","year":"2003"},{"issue":"22","key":"10.1016\/j.sapharm.2025.03.009_bib12","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1001\/jama.288.22.2880","article-title":"Helping patients follow prescribed treatment: clinical applications","volume":"288","author":"Haynes","year":"2002","journal-title":"Jama"},{"issue":"6","key":"10.1016\/j.sapharm.2025.03.009_bib13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s11606-007-0180-x","article-title":"Patients at-risk for cost-related medication nonadherence: a review of the literature","volume":"22","author":"Briesacher","year":"2007","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1016\/j.sapharm.2025.03.009_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.sapharm.2019.06.008","article-title":"Cost-related nonadherence to medicines in people with multiple chronic conditions","volume":"16","author":"Laba","year":"2020","journal-title":"Res Soc Adm Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2025.03.009_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-001475","article-title":"Coping with healthcare costs for chronic illness in low-income and middle-income countries: a systematic literature review","volume":"4","author":"Murphy","year":"2019","journal-title":"BMJ Glob Health"},{"issue":"9995","key":"10.1016\/j.sapharm.2025.03.009_bib16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Vos","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2025.03.009_bib17","series-title":"Global Status Report on Noncommunicable Diseases 2014","year":"2014"},{"issue":"17","key":"10.1016\/j.sapharm.2025.03.009_bib18","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"Jama"},{"key":"10.1016\/j.sapharm.2025.03.009_bib19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/164_2019_301","article-title":"Why are new drugs expensive and how can they stay affordable?","author":"Hammel","year":"2019","journal-title":"Concepts Principles of Pharmacology: 100 Years of the Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.sapharm.2025.03.009_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.archger.2018.06.018","article-title":"Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe","volume":"78","author":"Mid\u00e3o","year":"2018","journal-title":"Arch Gerontol Geriatr"},{"issue":"5","key":"10.1016\/j.sapharm.2025.03.009_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00228-013-1639-9","article-title":"Prevalence of polypharmacy in a Scottish primary care population","volume":"70","author":"Payne","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.sapharm.2025.03.009_bib22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2165\/11584990-000000000-00000","article-title":"Prevalence and risk of polypharmacy among the elderly in an outpatient setting","volume":"27","author":"Slabaugh","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.sapharm.2025.03.009_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1053515","article-title":"Multimorbidity and out-of-pocket expenditure on medicine in Europe: longitudinal analysis of 13 European countries between 2013 and 2015","volume":"10","author":"Palladino","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.sapharm.2025.03.009_bib24","unstructured":"OECD\/European Observatory on Health Systems and Policies. Ireland: Country Health Profile 2023, State of Health in the EU. OECD Publishing, Paris\/European Observatory on Health Systems and Policies, Brussels. Accessed 9 January, 2025. https:\/\/eurohealthobservatory.who.int\/publications\/m\/ireland-country-health-profile-2023."},{"key":"10.1016\/j.sapharm.2025.03.009_bib25","unstructured":"OECD\/European Observatory on Health Systems and Policies. Denmark: Country Health Profile 2023, State of Health in the EU. OECD Publishing. Accessed 22 January, 2025. https:\/\/eurohealthobservatory.who.int\/publications\/m\/denmark-country-health-profile-2023."},{"key":"10.1016\/j.sapharm.2025.03.009_bib26","author":"Johnston"},{"issue":"1","key":"10.1016\/j.sapharm.2025.03.009_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014287","article-title":"Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries","volume":"7","author":"Morgan","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.sapharm.2025.03.009_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jpsychores.2018.09.011","article-title":"Patterns of chronic physical multimorbidity in psychiatric and general population","volume":"114","author":"Filip\u010di\u0107","year":"2018","journal-title":"J Psychosom Res"},{"issue":"8","key":"10.1016\/j.sapharm.2025.03.009_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214183","article-title":"Multimorbidity, healthcare utilization and socioeconomic status: a register-based study in Denmark","volume":"14","author":"Fr\u00f8lich","year":"2019","journal-title":"PLoS One"},{"issue":"9836","key":"10.1016\/j.sapharm.2025.03.009_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"issue":"3-4","key":"10.1016\/j.sapharm.2025.03.009_bib31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1475-5890.2016.12119","article-title":"Medical spending in Denmark","volume":"37","author":"Christensen","year":"2016","journal-title":"Fiscal Stud"},{"issue":"3","key":"10.1016\/j.sapharm.2025.03.009_bib32","first-page":"798","article-title":"Data resource profile: the Danish national prescription registry","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"8","key":"10.1016\/j.sapharm.2025.03.009_bib33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"Von Elm","year":"2007","journal-title":"Ann Intern Med"},{"issue":"7_suppl","key":"10.1016\/j.sapharm.2025.03.009_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish national prescription registry","volume":"39","author":"Wallach Kildemoes","year":"2011","journal-title":"Scand J Publ Health"},{"key":"10.1016\/j.sapharm.2025.03.009_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"7 Suppl","key":"10.1016\/j.sapharm.2025.03.009_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1403494810394715","article-title":"Danish education registers","volume":"39","author":"Jensen","year":"2011","journal-title":"Scand J Publ Health"},{"issue":"4","key":"10.1016\/j.sapharm.2025.03.009_bib37","first-page":"441","article-title":"The Danish Civil Registration System. A cohort of eight million persons","volume":"53","author":"Pedersen","year":"2006","journal-title":"Dan Med Bull"},{"issue":"4","key":"10.1016\/j.sapharm.2025.03.009_bib38","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/1403494815575193","article-title":"Danish nationwide registers for public health and health-related research","volume":"43","author":"Erlangsen","year":"2015","journal-title":"Scand J Publ Health"},{"issue":"3","key":"10.1016\/j.sapharm.2025.03.009_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/aje\/kwv324","article-title":"The association between perceived stress and mortality among people with multimorbidity: a prospective population-based cohort study","volume":"184","author":"Prior","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.sapharm.2025.03.009_bib40","series-title":"Medicines Reimbursement Policies in Europe","author":"Vogler","year":"2018"},{"key":"10.1016\/j.sapharm.2025.03.009_bib41","series-title":"PPRI Report","author":"Vogler","year":"2008"},{"key":"10.1016\/j.sapharm.2025.03.009_bib45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10198-003-0165-6","article-title":"Pricing and reimbursement of drugs in Denmark","volume":"4","author":"M\u00f8ller Pedersen","year":"2003","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.sapharm.2025.03.009_bib50","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2307\/1909582","article-title":"Some statistical models for limited dependent variables with application to the demand for durable goods","author":"Cragg","year":"1971","journal-title":"Econometrica: J Econom Soc"},{"issue":"8","key":"10.1016\/j.sapharm.2025.03.009_bib51","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/hec.1653","article-title":"Review of statistical methods for analysing healthcare resources and costs","volume":"20","author":"Mihaylova","year":"2011","journal-title":"Health Econ"},{"issue":"1","key":"10.1016\/j.sapharm.2025.03.009_bib52","first-page":"1","article-title":"Analyzing health care costs: a comparison of statistical methods motivated by Medicare colorectal cancer charges","volume":"1","author":"Griswold","year":"2004","journal-title":"Biostatistics"},{"issue":"1","key":"10.1016\/j.sapharm.2025.03.009_bib53","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12913-021-06446-9","article-title":"Effect of multimorbidity on utilisation and out-of-pocket expenditure in Indonesia: quantile regression analysis","volume":"21","author":"Anindya","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"10.1016\/j.sapharm.2025.03.009_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-004042","article-title":"Medical costs and out-of-pocket expenditures associated with multimorbidity in China: quantile regression analysis","volume":"6","author":"Zhao","year":"2021","journal-title":"BMJ Glob Health"},{"issue":"1","key":"10.1016\/j.sapharm.2025.03.009_bib55","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12913-021-06446-9","article-title":"Effect of multimorbidity on utilisation and out-of-pocket expenditure in Indonesia: quantile regression analysis","volume":"21","author":"Anindya","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"10.1016\/j.sapharm.2025.03.009_bib56","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-004042","article-title":"Medical costs and out-of-pocket expenditures associated with multimorbidity in China: quantile regression analysis","volume":"6","author":"Zhao","year":"2021","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.sapharm.2025.03.009_bib57","series-title":"International Profiles of Health Care Systems","author":"Tikkanen","year":"2020"},{"key":"10.1016\/j.sapharm.2025.03.009_bib58","first-page":"1","article-title":"The US health system in perspective: a comparison of twelve industrialized nations","volume":"16","author":"Squires","year":"2011","journal-title":"Issue Brief (Public Policy Inst Am Assoc Retired Persons)"},{"issue":"4","key":"10.1016\/j.sapharm.2025.03.009_bib59","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/1077558711399580","article-title":"Health care utilization and costs of elderly persons with multiple chronic conditions","volume":"68","author":"Lehnert","year":"2011","journal-title":"Med Care Res Rev"},{"key":"10.1016\/j.sapharm.2025.03.009_bib60","unstructured":"OECD\/European Observatory on Health Systems and Policies. Denmark: Country Health Profile 2021, State of Health in the EU. OECD Publishing. Accessed 26 July, 2023. https:\/\/www.oecd.org\/health\/denmark-country-health-profile-2021-2dce8636-en.htm."},{"issue":"3","key":"10.1016\/j.sapharm.2025.03.009_bib63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jphs.12180","article-title":"Tendering for off-patent outpatient medicines: lessons learned from experiences in Belgium, Denmark and The Netherlands","volume":"8","author":"Vogler","year":"2017","journal-title":"J Pharmaceut Health Serv Res"},{"issue":"1","key":"10.1016\/j.sapharm.2025.03.009_bib65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher","year":"2014","journal-title":"Expet Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.sapharm.2025.03.009_bib66","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.298.1.61","article-title":"Prescription drug cost sharing: associations with medication and medical utilization and spending and health","volume":"298","author":"Goldman","year":"2007","journal-title":"Jama"},{"key":"10.1016\/j.sapharm.2025.03.009_bib67","series-title":"Inequality in Denmark through the Looking Glass","author":"Causa","year":"2016"},{"issue":"4","key":"10.1016\/j.sapharm.2025.03.009_bib68","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/bcpt.13772","article-title":"Free\u2010of\u2010charge dispensing of antipsychotics for schizophrenia in Denmark: impact on the nationwide prescription registry and redemption of somatic medications","volume":"131","author":"Rohde","year":"2022","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.sapharm.2025.03.009_bib69","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s12889-017-4314-8","article-title":"Social disparities in the prevalence of multimorbidity - a register-based population study","volume":"17","author":"Schi\u00f8tz","year":"2017","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.sapharm.2025.03.009_bib70","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","article-title":"Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care","volume":"10","author":"De Hert","year":"2011","journal-title":"World Psychiatry"},{"key":"10.1016\/j.sapharm.2025.03.009_bib73","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h176","article-title":"Managing patients with multimorbidity in primary care","volume":"350","author":"Wallace","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2025.03.009_bib74","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12913-016-1353-2","article-title":"Patient-physician discussions about costs: definitions and impact on cost conversation incidence estimates","volume":"16","author":"Hunter","year":"2016","journal-title":"BMC Health Serv Res"},{"issue":"16","key":"10.1016\/j.sapharm.2025.03.009_bib75","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJMp1306826","article-title":"Full disclosure--out-of-pocket costs as side effects","volume":"369","author":"Ubel","year":"2013","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.sapharm.2025.03.009_bib76","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/archinte.165.15.1749","article-title":"The role of patient-physician trust in moderating medication nonadherence due to cost pressures","volume":"165","author":"Piette","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sapharm.2025.03.009_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2023.116337","article-title":"Temporal capital and unaligned times as inequality mechanisms: a case study of chronic care in general practice","volume":"338","author":"Paust","year":"2023","journal-title":"Soc Sci Med"},{"issue":"4","key":"10.1016\/j.sapharm.2025.03.009_bib78","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.sapharm.2016.08.005","article-title":"Pharmacist-led medication review in community settings: an overview of systematic reviews","volume":"13","author":"Jokanovic","year":"2017","journal-title":"Res Soc Adm Pharm"},{"issue":"2","key":"10.1016\/j.sapharm.2025.03.009_bib79","article-title":"Systematic medication review in general practice by an interdisciplinary team: a thorough but laborious method to address polypharmacy among elderly patients","volume":"8","author":"Dalin","year":"2020","journal-title":"Pharmacy (Basel)"},{"issue":"3","key":"10.1016\/j.sapharm.2025.03.009_bib80","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041541","article-title":"Integrating clinical pharmacists within general practice: protocol for a pilot cluster randomised controlled trial","volume":"11","author":"Croke","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.sapharm.2025.03.009_bib81","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11096-006-9008-8","article-title":"Drug-related problems in general practice: results from a development project in Denmark","volume":"28","author":"Soendergaard","year":"2006","journal-title":"Pharm World Sci"},{"issue":"1","key":"10.1016\/j.sapharm.2025.03.009_bib82","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.18549\/PharmPract.2021.1.2212","article-title":"Integration of and visions for community pharmacy in primary health care in Denmark","volume":"19","author":"Hansen","year":"2021","journal-title":"Pharm Pract (Granada)"},{"key":"10.1016\/j.sapharm.2025.03.009_bib83","series-title":"Financial Hardship and Out-Of-Pocket Expenditure","year":"2019"},{"issue":"3","key":"10.1016\/j.sapharm.2025.03.009_bib84","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11673-019-09929-x","article-title":"Planning ahead for dementia research participation: insights from a survey of older Australians and implications for ethics, law and practice","volume":"16","author":"Ries","year":"2019","journal-title":"J bioeth Inq"},{"key":"10.1016\/j.sapharm.2025.03.009_bib85","author":"Prior"},{"issue":"8","key":"10.1016\/j.sapharm.2025.03.009_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253944","article-title":"Patterns of prescription dispensation and over-the-counter medication sales in Sweden during the COVID-19 pandemic","volume":"16","author":"Karlsson","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.sapharm.2025.03.009_bib88","author":"Kvist"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125000889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125000889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:26:37Z","timestamp":1762550797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741125000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1551741125000889"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.03.009","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.11.21.23298458","asserted-by":"object"}]},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between multimorbidity and out-of-pocket expenditure for prescription medicines among adults in Denmark: A population-based register study","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}